Latest Breaking News On - Consilium strategic communications financial media - Page 1 : comparemela.com

Investegate |Synairgen plc Announcements | Synairgen plc: SPRINTER Trial Results Published

Investegate announcements from Synairgen plc, SPRINTER Trial Results Published

United statesSan franciscoNamrata taakGeoff nashMary conwayDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneNumis securities limited joint brokerHead of communicationsDrug administration

Investegate |Synairgen plc Announcements | Synairgen plc: Data from the US NIH-led ACTIV-2 Phase 2 trial

Investegate announcements from Synairgen plc, Data from the US NIH-led ACTIV-2 Phase 2 trial

Namrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeWilliam fischerJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneNumis securities limited joint brokerHead of communicationsNational institutes of health

Synairgen plc: Synairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19

Fewer participants treated with SNG001 compared to placebo progressed to hospitalisation (1/110 vs 7/110, P=0.07) SNG001 was well-tolerated with a favourable safety profile consistent with

Namrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeWilliam fischerJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneNumis securities limited joint brokerHead of communicationsNational institutes of health

Synairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19

Synairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Namrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeWilliam fischerJames blackMary jane elliottRatko djukanovicFreddie barnfieldLucy featherstoneNumis securities limited joint brokerHead of communicationsNational institutes of health

Synairgen plc: Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022

Analysis of 60 and 90-day data from Phase 3 SPRINTER trial in hospitalised COVID-19 patients showed that SNG001 reduced risk of recognised Long COVID symptoms Company to present full analysis

United statesNamrata taakGeoff nashMary conwayRichard marsdenDonna daviesDuncan monteithBrooke clarkeJames blackMary jane elliottRatko djukanovicFreddie barnfieldChris brightlingLucy featherstoneNumis securities limited joint brokerHead of communications